NASDAQ:TMDX | Insider Transactions — Page 5 | TransMedics Group, Inc.

TMDX Insider Transactions — Page 5

447 retained open-market purchase and sale rows from SEC Forms 3, 4 and 5, newest first. This page shows rows 401–447; provenance stays internal.

Insider profileRoleDateTransactionSharesPrice
Gordon StephenChief Financial Officer2021-02-16Sale10,000.0$31.33
Sullivan John FVP of Quality & Engineering2021-02-09Sale200.0$34.18
Sullivan John FVP of Quality & Engineering2021-02-09Sale8,400.0$32.78
TOBIN JAMES RDirector2021-02-09Sale200.0$34.18
TOBIN JAMES RDirector2021-02-09Sale9,968.0$32.8
ABRAMS CAPITAL, LLCTenPercentOwner2021-02-09Sale786,664.0$33.32
ABRAMS CAPITAL MANAGEMENT, LLCTenPercentOwner2021-02-09Sale786,664.0$33.32
Abrams David CTenPercentOwner2021-02-09Sale786,664.0$33.32
Abrams Capital Partners II, L.P.TenPercentOwner2021-02-09Sale786,664.0$33.32
ABRAMS CAPITAL MANAGEMENT, L.P.TenPercentOwner2021-02-09Sale786,664.0$33.32
Riva Capital Partners III, L.P.TenPercentOwner2021-02-09Sale786,664.0$33.32
Riva Capital Management III, LLCTenPercentOwner2021-02-09Sale786,664.0$33.32
Gordon StephenChief Financial Officer2021-02-08Sale1,429.0$25.01
Gordon StephenChief Financial Officer2021-02-08Sale8,571.0$25.01
ABRAMS CAPITAL, LLCTenPercentOwner2021-02-08Sale88,483.0$26.24
ABRAMS CAPITAL MANAGEMENT, LLCTenPercentOwner2021-02-08Sale88,483.0$26.24
Abrams David CTenPercentOwner2021-02-08Sale88,483.0$26.24
Abrams Capital Partners II, L.P.TenPercentOwner2021-02-08Sale88,483.0$26.24
ABRAMS CAPITAL MANAGEMENT, L.P.TenPercentOwner2021-02-08Sale88,483.0$26.24
Riva Capital Partners III, L.P.TenPercentOwner2021-02-08Sale88,483.0$26.24
Riva Capital Management III, LLCTenPercentOwner2021-02-08Sale88,483.0$26.24
Sullivan John FVP of Quality & Engineering2021-01-19Sale9,617.0$22.12
Gordon StephenChief Financial Officer2021-01-04Sale1,184.0$20.0
Gordon StephenChief Financial Officer2020-12-31Sale8,816.0$20.0
Sullivan John FVP of Quality & Engineering2020-12-21Sale1,000.0$17.99
Sullivan John FVP of Quality & Engineering2020-12-15Sale3,000.0$16.63
Carey John FVP of Operations2020-09-01Sale2,000.0$17.59
Carey John FVP of Operations2020-08-03Sale142.0$18.96
Carey John FVP of Operations2020-08-03Sale1,858.0$18.58
Carey John FVP of Operations2020-07-01Sale600.0$17.92
Carey John FVP of Operations2020-07-01Sale1,400.0$16.73
Carey John FVP of Operations2020-06-01Sale2,000.0$13.21
Carey John FVP of Operations2020-05-01Sale500.0$17.63
Carey John FVP of Operations2020-05-01Sale1,500.0$16.86
Gordon StephenChief Financial Officer2020-04-27Sale9,900.0$18.0
Gordon StephenChief Financial Officer2020-04-22Sale100.0$18.0
Carey John FVP of Operations2020-04-07Sale2,000.0$13.1
Carey John FVP of Operations2020-03-02Sale100.0$15.98
Carey John FVP of Operations2020-03-02Sale1,900.0$15.13
Carey John FVP of Operations2020-02-03Sale2,000.0$17.71
Khayal Tamer IChief Commercial Officer2020-01-21Sale5,000.0$20.02
Carey John FVP of Operations2020-01-02Sale2,000.0$18.95
UNITED THERAPEUTICS CorpTenPercentOwner2019-12-09Sale500,000.0$18.75
Lung Biotechnology PBCTenPercentOwner2019-12-09Sale500,000.0$18.75
Weill DavidDirector2019-11-11Purchase10,000.0$17.0
KANIA EDWIN M JRDirector2019-05-06Purchase33,333.0$16.0
Basile Edward MDirector2019-05-06Purchase8,500.0$16.0